Document is current
Any future updates will be listed below
-
Authors
Luckraz, Heyman https://orcid.org/0000-0003-1218-1243
Giri, Ramesh
Wrigley, Benjamin
Nagarajan, Kumaresan
Senanayake, Eshan
Sharman, Emma
Beare, Lawrence
Nevill, Alan
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02974946 at ClinicalTrials.govDocuments that mention this clinical trial
The use of the RenalGuard system in cardiac surgery with cardiopulmonary bypass: a first in man prospective, observational, feasibility pilot study
https://doi.org/10.1136/openhrt-2017-000669
Balanced forced-diuresis compared to control as a reno-protective approach in cardiac surgery: secondary outcome of a randomized controlled trial, assessment of neutrophil gelatinase-associated lipocalin levels
https://doi.org/10.1186/s13019-021-01620-w
-
Funding
Funding for this research was provided by:
RenalGuard plc
National Institute for Health Research (NIHR ID: 32769)
- License Information
-
More Information
Article History
Received: 25 February 2021
Accepted: 12 August 2021
First Online: 24 August 2021
Declarations
:
: This study was approved by the Ethical committee (16/NI/0246, 2<sup>nd</sup> December 2016). Informed written consent was obtained from each patient pre-operatively.
: Not applicable.
: This study was funded by a research grant from RenalGuard Solutions and there are no other competing interests to declare.
